Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran

Publisher： Karger

E-ISSN： 1421-9786|30|5|533-534

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.30, Iss.5, 2010-09, pp. : 533-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 288-295

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis in German Stroke Units before and after Regulatory Approval of Recombinant Tissue Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 429-431

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis for Acute Ischaemic Stroke: Preliminary Experience with Recombinant Tissue Plasminogen Activator in the UK

By  

Cerebrovascular Diseases, Vol. 20, Iss. 6, 2005-11 ,pp. : 438-442

Karger

Access to resources Recommend Favorite

Fatal Intracerebral Hemorrhage Associated with Administration of Recombinant Tissue Plasminogen Activator in a Stroke Patient on Treatment with Dabigatran

By  

Cerebrovascular Diseases, Vol. 32, Iss. 6, 2011-12 ,pp. : 614-615

Karger

Access to resources Recommend Favorite

Effects of Uric Acid Levels on Outcome in Severe Ischemic Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator

By  

European Neurology, Vol. 71, Iss. 3-4, 2013-12 ,pp. : 132-139

Karger

Access to resources Recommend Favorite